...

Module

Inflammation and Non-AIDS Events: Are Antiretroviral-Treated Patients Aging Too Quickly and If So, Why?

Source: HIV/AIDS Annual Update 2009

Inflammation and Non-AIDS Events: Are Antiretroviral-Treated Patients Aging Too Quickly and If So, Why?


Program Director: W. David Hardy, MD

Faculty:

Steven G. Deeks, MD
  • Steven G. Deeks, MD

CREDIT INFORMATION

Release Date: May 22, 2009

Expiration Date: May 21, 2010


Physicians: maximum of 1.0 AMA PRA Category 1 Credit

Registered Nurses: 1.0 Nursing contact hour

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: The activity is not currently available for credit.


Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the findings of studies regarding the relationships among HIV infection, antiretroviral therapy, and the development of non-AIDS events in HIV-infected patients
  • Describe data that indicate differences in life expectancy between treated HIV-infected patients and those who are uninfected
  • Summarize potential mechanisms for the interaction between HIV infection and development of non-AIDS events

Topics covered include:

  • Introduction
  • Untreated HIV Disease Increases the Risk of Diseases Associated With Aging
  • Life Expectancy in Antiretroviral-Treated Patients Is Lower Than in the General Population and Predicted by CD4+ T-Cell Counts
  • HIV Infection Is Associated With Increased Risk of Age-Associated Non-AIDS Diseases
  • Mechanisms for Premature Aging and Increased Risk of Non-AIDS Morbidity/Mortality During Long-term HAART
  • Inflammation and HIV-Associated Aging
  • Mechanisms for Persistent Inflammation During HAART
  • Conclusions


Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.